Failed Execution in Tennessee Sparks Renewed Debate on Lethal Injection Protocols
In a troubling incident that has reignited discussions about execution protocols, Christa Pike, a woman from Tennessee, survived a failed execution attempt on Wednesday. This occurrence is not isolated, as scrutiny over Tennessee’s execution methods has been ongoing for years.
Sacha Pfeiffer, an NPR host, highlighted the situation: “This woman, Christa Pike, remains in the hospital after the state of Tennessee tried and failed to execute her yesterday.” Chiara Eisner, an NPR investigative correspondent with extensive experience covering executions, shared insights on the incident.
According to Eisner, Pike’s attorney reported limited access to their client, yet confirmed she suffered blistering and burning on her arm and is receiving medical attention. Despite two doses of the lethal injection drug pentobarbital being administered, Pike remained alive, with witnesses reporting hearing her snoring after the second dose.
Patterns of Execution Failures
This case marks the first known instance of someone surviving two doses of pentobarbital, yet it is not uncommon for executions to deviate from plan. A similar incident occurred last May in Tennessee with inmate Tony Carruthers. Maria DeLiberato, Carruthers’ lawyer, recounted the distressing scene where execution staff struggled for an hour to administer the lethal injection correctly, ultimately leading to the procedure being halted.
DeLiberato stated, “Tony was in agony, moaning in guttural pain. There was blood. It took close to an hour. And eventually, they called off the execution.” Both Pike and Carruthers remain alive today.
Systemic Issues and Investigation Findings
The repeated failures prompted Tennessee Governor Bill Lee to order an investigation in 2022, revealing consistent protocol violations and leading to a temporary pause in executions. Following the recent incident with Pike, executions have once again been paused.
Such issues are not confined to Tennessee. Nationwide, states and the federal government have examined lethal injection practices. The Department of Justice, under the Biden administration, released findings suggesting lethal injections pose excessive risks of pain and error, advocating for discontinuation.
Challenges with Lethal Injection Drugs
The ongoing problems partly stem from the drugs used. Major U.S. pharmaceutical companies refuse to supply drugs for executions, forcing states to obtain them from smaller pharmacies with questionable standards. Eisner reported that Texas sourced pentobarbital from a compounding pharmacy with multiple safety violations. Additionally, there have been instances where expired or incorrect drugs were used.
Concerns Over Staff Qualifications
Another factor contributing to execution mishaps is the potential lack of medical qualifications among staff. States often keep staff details confidential, citing privacy concerns. However, lawsuits argue that transparency regarding execution team qualifications is owed to the public and inmates. Pike’s lawyers alleged that personnel inadequately trained in drug administration inflicted unnecessary harm, raising claims of cruel and unusual punishment.
Eisner concluded her discussion with Pfeiffer, emphasizing the need for scrutiny and reform in the execution process.
This article was originally written by www.npr.org
